KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Deferred Taxes (2017 - 2023)

Elanco Animal Health's Deferred Taxes history spans 7 years, with the latest figure at $2.0 million for Q1 2023.

  • For Q1 2023, Deferred Taxes rose 128.57% year-over-year to $2.0 million; the TTM value through Mar 2023 reached -$48.0 million, up 62.2%, while the annual FY2025 figure was -$134.0 million, 19.64% down from the prior year.
  • Deferred Taxes for Q1 2023 was $2.0 million at Elanco Animal Health, up from -$29.0 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $35.0 million in Q4 2020 and bottomed at -$92.0 million in Q2 2021.
  • The 5-year median for Deferred Taxes is -$25.0 million (2020), against an average of -$19.3 million.
  • The largest YoY upside for Deferred Taxes was 779.17% in 2019 against a maximum downside of 1511.11% in 2019.
  • A 5-year view of Deferred Taxes shows it stood at -$14.9 million in 2019, then soared by 334.9% to $35.0 million in 2020, then tumbled by 174.29% to -$26.0 million in 2021, then decreased by 11.54% to -$29.0 million in 2022, then surged by 106.9% to $2.0 million in 2023.
  • Per Business Quant, the three most recent readings for ELAN's Deferred Taxes are $2.0 million (Q1 2023), -$29.0 million (Q4 2022), and $6.0 million (Q3 2022).